Pune, India -- (SBWire) -- 04/10/2019 --The report on Erectile Dysfunction Drugs Market by drug (sildenafil (Viagra), tadalafil (Cialis), vardenafil (levitra, staxyn), avanafil (stendra), muse suppository (alprostadil)), mode of administration (oral, topical, injections), end-user (hospital pharmacies, retail pharmacies, and online pharmacies) trends analysis and forecasts up to 2024 studies the market sizes, key trends, Industry Analysis, Trends, Size, Share and Forecasts to 2024 and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Erectile Dysfunction Drugs Market is projected to grow at a CAGR in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by a significant contribution by North America (Leading region) region to this market. The global erectile dysfunction drugs market is projected to grow at a CAGR of 6.8% over the forecast period of 2018-2024.
Get Sample Report Copy for Market Insights @ https://www.infiniumglobalresearch.com/reports/sample-request/1967
Increasing Aging Population and Stressful Lifestyle to Drive the Growth of the Erectile Dysfunction Drugs Market
The growing prevalence of erectile dysfunction owing to the increase in levels of stress, hypertension, heart diseases, and obesity is driving the growth of the erectile dysfunction drugs market. The growing elderly population contributes to the growth of erectile dysfunction drugs market. The shifting lifestyle trends such as unhealthy diet, physical inactivity, cigarette smoking, and harmful use of alcohol are the major factors responsible for the increasing occurrences of erectile dysfunction. The rising consciousness about such medical conditions and a high rate of chronic diseases will increase the demand for erectile dysfunction drugs over the forecast period.
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1967
Sildenafil Drug to Dominate the Dysfunction Drug Market
The report on erectile dysfunction drugs market is bifurcated into a drug, mode of administration, and end-user. The drugs segment include sildenafil (Viagra), tadalafil (Cialis), vardenafil (levitra,staxyn), avanafil (stendra), muse suppository (alprostadil), and other drugs. Among these drugs, sildenafil holds the maximum market share in the erectile dysfunction drug market as it is widely used and prescribed by doctors for more than 64 million men worldwide. In addition, the ongoing developments in drug delivery techniques drive the growth of the market.
North America to Hold the Dominant Share in the Erectile Dysfunction Drug Market
North America holds the largest share in the erectile dysfunction drug market. The rising prevalence of erectile dysfunction in the North America region owing to the stressful lifestyle and growing awareness about the ED drugs for curing erectile dysfunction drives the growth of erectile dysfunction drug market in this region. The expiry of patents of several erectile dysfunction drugs is anticipated to drive the growth of the North America dysfunction drug market over the forecast period. Moreover, people in the North America region have high capacity in healthcare expenditure continues to be an added incentive for the growth of the erectile dysfunction drug market. Asia-Pacific is the fastest growing in the erectile dysfunction drug market. The rise in the elderly population and growing awareness about erectile dysfunction in the Asia Pacific region drives the growth of erectile dysfunction drug market in this region.
Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-erectile-dysfunction-drugs-market
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the Erectile Dysfunction Drugs.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
